Related Experiment Video
Updated: Jun 12, 2026
05:31
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Transarterial Therapy for Liver Tumors.
Zuzanna Kobus1, Anita Karimi1, Hooman Yarmohammadi1
1Division of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Hematology/Oncology Clinics of North America
|June 10, 2026
Summary
Transarterial therapies (TATs) offer targeted locoregional treatment for unresectable liver tumors by exploiting the liver
Area of Science:
- Hepatology and Interventional Radiology
- Oncology
- Vascular Medicine
Background:
- Liver tumors, both primary and secondary, pose a significant global health burden.
- Many cases are diagnosed when curative surgical options are unavailable.
- Locoregional therapies are crucial for managing unresectable liver malignancies.
Purpose of the Study:
- To provide a comprehensive review of transarterial therapies (TATs) for liver tumors.
- To focus on patient selection, procedural techniques, and clinical outcomes.
- To cover both primary and secondary liver malignancies.
Main Methods:
- Review of existing literature on transarterial therapies.
- Analysis of different TAT modalities: embolization, chemoembolization, and radioembolization.
- Discussion of the liver's dual blood supply in targeted therapy.
Main Results:
- TATs selectively target tumor tissue while sparing healthy liver parenchyma.
- Different TATs have distinct mechanisms, technical requirements, and applications.
- The review synthesizes evidence on the effectiveness of TATs in various liver cancer types.
Conclusions:
- Transarterial therapies are essential treatment options for unresectable liver tumors.
- Careful patient selection and understanding procedural principles are key to successful outcomes.
- TATs represent a vital strategy in the multidisciplinary management of liver malignancies.
